RESTEN-MP

· Sarepta Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RESTEN-MP, covering 2007-02-08 to 2008-04-10. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis [Phase 1]